Three-time NARSAD Grantee talks about his groundbreaking work on depression since the 1980s
When did your research career begin, and what made you pursue research on depression in particular?
My...
- Mental Illnesses
- Discoveries
- Finding Answers
- Recovery Stories
- NARSAD Grants & Prizes
- Apply for a NARSAD Grant
- Our Scientific Council
- NARSAD Young Investigator Grant
- NARSAD Independent Investigator Grants
- NARSAD Distinguished Investigator Grant
- Klerman & Freedman Prizes
- Outstanding Achievement Prizes
- Productive Lives Awards
- Productive Lives Nomination Form
- Frequently Asked Questions (FAQs)
- Get Involved
You are here
Discoveries ›Next Generation Therapies
Patients with depression tend to smoke a lot, which led to the idea that nicotine may ease depressive symptoms. Research has shown how the process works. Nicotine binds to particular receptor molecules on the surface of...
Schizophrenia-associated deficits in cognition are not substantially improved by medication, but have been shown to improve with remedial cognitive training. The mechanisms that support this improvement have been largely...
A team of neuroscientists led by NARSAD Young Investigator Grantee and Scientific Council Member Karl Deisseroth, M.D., Ph.D., has demonstrated for the first time how dopamine neurons are linked to depression. The team at...
Carmine M. Pariante, M.D., Ph.D., Professor of Biological Psychiatry at King’s College London’s Institute of Psychiatry, is one of the authors of a new study that identifies the signaling pathway in the brain that, when...
Pages
Research by Illness
|
The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. |
DONATE NOW |










